CNBCUPDATE: Amgen 2Q Profit Beats Street On Anemia Drug SalesCNNMoney.com - 32 minutes agoNEW YORK -(Dow Jones)- Amgen Inc.s (AMGN) second-quarter profit dropped 7.7% but better-than-expected sales of its beleaguered anemia drugs prompted a boost in 2008 guidance.Amgen reports 8% drop in profit MarketWatchAmgen Profit Beats Estimates; Forecast Raised (Update1) BloombergReuters - Forbes - The Associated Press - TheStreet.comall 163 news articles
Google News
